Non-coding RNAs in hypertrophic scars and keloids: Current research and clinical relevance: A review

被引:10
作者
Su, Linlin [1 ]
Han, Juntao [1 ,2 ]
机构
[1] Air Force Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi, Peoples R China
[2] 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Hypertrophic scar; Keloid; miRNAs; lncRNAs; circRNAs; EXPRESSION PROFILES; TGF-BETA/SMAD; FIBROBLASTS; PROLIFERATION; GROWTH; PROGRESSION; MIGRATION; APOPTOSIS; PROMOTES; PROTEINS;
D O I
10.1016/j.ijbiomac.2023.128334
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypertrophic scars (HS) and keloids (KD) are lesions that develop as a result of excessive fibroblast proliferation and collagen deposition in response to dermal injury, leading to dysregulation of the inflammatory, proliferative, and remodeling phases during wound healing. HS and KD affect up to 90 % of the population and are associated with lower quality of life, physical health, and mental status in patients. Efficient targeted treatment represents a significant challenge, primarily due to our limited understanding of their underlying pathogenesis. Non-coding RNAs (ncRNAs), which constitute a significant portion of the human transcriptome with minimal or no proteincoding capacity, have been implicated in various cellular physiologies and pathologies and may serve as diagnostic indicators or therapeutic targets. NcRNAs have been found to be aberrantly expressed and regulated in HS and KD. This review provides a summary of the expression profiles and molecular mechanisms of three common ncRNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), in HS and KD. It also discusses their potential as biomarkers for the diagnosis and treatment of these diseases and provides novel insights into epigenetic-based diagnosis and treatment strategies for HS and KD.
引用
收藏
页数:12
相关论文
共 168 条
[1]   Macrophage Phenotypes in Normal and Diabetic Wound Healing and Therapeutic Interventions [J].
Al Sadoun, Hadeel .
CELLS, 2022, 11 (15)
[2]   Hypertrophic scars and keloids - Etiology and management [J].
Alster, TS ;
Tanzi, EL .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2003, 4 (04) :235-243
[3]   The role of microRNAs in skin fibrosis [J].
Babalola, Olubukola ;
Mamalis, Andrew ;
Lev-Tov, Hadar ;
Jagdeo, Jared .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2013, 305 (09) :763-776
[4]   Growth factors and cytokines in wound healing [J].
Barrientos, Stephan ;
Stojadinovic, Olivera ;
Golinko, Michael S. ;
Brem, Harold ;
Tomic-Canic, Marjana .
WOUND REPAIR AND REGENERATION, 2008, 16 (05) :585-601
[5]   Transforming Growth Factor-β Signaling in Immunity and Cancer [J].
Batlle, Eduard ;
Massague, Joan .
IMMUNITY, 2019, 50 (04) :924-940
[6]   Long Noncoding RNA and Cancer: A New Paradigm [J].
Bhan, Arunoday ;
Soleimani, Milad ;
Mandal, Subhrangsu S. .
CANCER RESEARCH, 2017, 77 (15) :3965-3981
[7]   Bioinformatic Analysis of Key Genes and Pathways Related to Keloids [J].
Bi, Siwei ;
Liu, Ruiqi ;
Wu, Beiyi ;
He, Linfeng ;
Gu, Jun .
BIOMED RESEARCH INTERNATIONAL, 2021, 2021
[8]   Long Non-Coding RNA uc003jox.1 Promotes Keloid Fibroblast Proliferation and Invasion Through Activating the PI3K/AKT Signaling Pathway [J].
Bu, Wenbo ;
Fang, Fang ;
Zhang, Mengli ;
Zhou, Wuqing .
JOURNAL OF CRANIOFACIAL SURGERY, 2023, 34 (02) :556-560
[9]   Currently known risk factors for hypertrophic skin scarring: A review [J].
Butzelaar, L. ;
Ulrich, M. M. W. ;
van der Molen, A. B. Mink ;
Niessen, F. B. ;
Beelen, R. H. J. .
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2016, 69 (02) :163-169
[10]   Wnt Signaling Pathway Proteins in Scar, Hypertrophic Scar, and Keloid: Evidence for a Continuum? [J].
Chaudet, Kristine M. ;
Goyal, Amrita ;
Veprauskas, Katy R. ;
Nazarian, Rosalynn M. .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2020, 42 (11) :842-847